AlphaQuest’s Avidity Biosciences RNAM Stock Holding History

AlphaQuest’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,450	Closed	-$105K	–	1651
2025 Q4	$105K	Buy	1,450 +850	+142%	+$54.9K	0.01%	1727
2025 Q3	$26.1K	Buy	600 +331	+123%	+$13.4K	﹤0.01%	2053
2025 Q2	$7.64K	Buy	+269	New	+$8.02K	﹤0.01%	1869
2024 Q4	–	Sell	-2,031	Closed	-$93.3K	–	1964
2024 Q3	$93.3K	Buy	2,031 +1,392	+218%	+$60.4K	0.01%	1299
2024 Q2	$26.1K	Sell	639 -683	-52%	-$19.6K	﹤0.01%	1275
2024 Q1	$33.7K	Sell	1,322 -21,942	-94%	-$344K	0.01%	975
2023 Q4	$211K	Buy	+23,264	New	+$156K	0.04%	603

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

AlphaQuest's RNAM Position: Q1 2026 in Review

AlphaQuest sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 1,450 shares — an estimated $105K sold.

AlphaQuest first reported a position in RNAM in Q4 2023 and held it in 7 quarters. The position peaked at $211K in Q4 2023. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

AlphaQuest reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
AlphaQuest sold 1,450 Avidity Biosciences shares in Q1 2026, an estimated $105K.
AlphaQuest first reported a position in Avidity Biosciences in Q4 2023 and held it in 7 quarters.
AlphaQuest's Avidity Biosciences position peaked at $211K in Q4 2023.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.